The significance of anticardiolipin antibodies in patients with lupus nephritis

Lupus

Volumn 5, Issue 1, 1996, Pages 70-73

  Abu Shakra, M ^a   Urowitz, M B ^a,b   Gladman, D D ^a   Ritchie, S ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Anticardiolipin; Lupus; Nephritis

Indexed keywords

CARDIOLIPIN ANTIBODY;

ADOLESCENT; ADULT; ARTERIOLE; ARTERY INTIMA PROLIFERATION; ARTICLE; CLINICAL ARTICLE; DISEASE CLASSIFICATION; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSIS; GLOMERULUS; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBUS; VASCULAR LESION;

EID: 0030040410     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339600500113     Document Type: Article

References (18)

1. Asherson RA, Kant KS: Antiphospholipid antibodies and the kidney. J Rheumatol 1993; 20: 1268-72.
2. Amigo MC, Garcia-Torres R, Robles M, Bochicchio T, Reyes PA: Renal involvement in primary antiphospholipid syndrome. J Rheumatol 1992; 19: 1181-5.
3. Kincaid-Smith P, Fairley KF, Kloss M: Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy related renal failure. Quart J Med 1988; 68: 795-815.
4. Magil AB, McFadden D, Rae A: Lupus glomerulonephritis with thrombotic microangiopathy. Human Pathol 1986; 17: 192-4.
5. Frampton G, Hicks J, Cameron JS: Significance of antiphospholipid antibodies in patients with lupus nephritis. Kidney Intern 1991; 39: 1225-31.
6. D'Agati V, Junis CH, Williams G, Appel GB: Anti-cardiolipin antibody and renal disease: a report of three cases. J Am Soc Nephrol 1990; 1: 777-84.
7. Hughson MD, Nadasdy T, McCarty GA, Choler C, Min KW, Silva F: Am J Kid Dis 1992; 20: 150-8.
8. Farrugia E, Torres VE, Gastineau D, Michet CJ, Holley KE: Lupus anticoagulant in systemic lupus erythematosus: a clinical and renal pathological study. Am J Kid Dis 1992; 20: 463-71.
9. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
10. Bombardier C, Gladman D, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. Arthritis Rheum 1992; 35: 630-40.
11. Harris EV, Gharavi AE, Patel S, Hughes GRV: Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April, 1986. Clin Exp Immunol 1987; 68: 215-22.
12. Austin HA, Muenz LR, Joyce KM, Antonovich TT, Kullick ME, Klippel JH, Decker JL, Balow JE. Prognostic factors in lupus nephritis: Contribution of renal histologic data. Am J Med 1983; 75: 382-91.
13. Asherson RA, Khamushta MA, Ordi-Ros J et al. The primary antiphospholipid syndrome: Major clinical and serological features. Medicine 1989; 68: 366-74.
14. Bakimer R, Fishman P, Blank M, Sredni B, Djaldetti M, Shoenfeld Y: Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody. J Clin Invest 1992; 89: 1558-63.
15. Piette JC, Cacoub P, Wechsler B: Renal manifestations of the antiphospholipid syndrome. Semin Arthritis Rheum 1994; 23: 357-66.
16. Love PE, Santovo SA: Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med 1990; 112: 682-98.
17. Abu Shakra M, Urowitz M, Gladman D, Farewell V: The significance of anticardiolipin antibodies in SLE. Clinical and laboratory correlations. Am J Med (In press).
18. Clueck HI, Kant ICS, Weiss MA, Pollak VE, Miller MA, Coots M: Thrombosis in systemic lupus erythematosus. Arch Int Med 1984; 145: 1389-95.